“…255 Large doses of heparin given as a bolus can precipitate hypotension, which is thought to be related to histamine release as the hemodynamic response can be blocked by histamine 1 and 2 receptor blockers. 256,257 The efficacy of heparin is attributed to an impairment of clot propagation and the prevention of recurrent PE. 258 The risk of recurrent venous thromboembolism is highest in the early stages, 259,260 and, because recurrent PE is reported to be the most common cause of death in hemodynamically stable patients, 3,41 it is crucial to rapidly achieve a therapeutic level of anticoagulation.…”